Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

about

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

Item

http://www.wikidata.org/entity/Q49167584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@en

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@nl

type

Item

label

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@en

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@nl

prefLabel

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@en

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@nl

P1476

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.

@en

P2093

Alexander R van Rosendael

http://www.w3.org/2001/XMLSchema#string

Andrea E van der Meulen-de Jong

http://www.w3.org/2001/XMLSchema#string

Elke de Jong

http://www.w3.org/2001/XMLSchema#string

Elsemieke I Plasmeijer

http://www.w3.org/2001/XMLSchema#string

Frank Hoentjen

http://www.w3.org/2001/XMLSchema#string

Iris D Nagtegaal

http://www.w3.org/2001/XMLSchema#string

Lauranne A A P Derikx

http://www.w3.org/2001/XMLSchema#string

Loes H C Nissen

http://www.w3.org/2001/XMLSchema#string

Lucy I H Overbeek

http://www.w3.org/2001/XMLSchema#string

Marieke Pierik

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study.

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Better survival of renal cell carcinoma in patients with inflammatory bowel disease

Melanoma in organ transplant recipients: the old enemy finds a new battleground.

Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.

P304

2018-2026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001191

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rob Verhoeven

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28837522

http://www.w3.org/2001/XMLSchema#string